Abstract:Abstract Background The gut microbiota (GM) and their metabolites have garnered significant attention for their roles in metabolic syndrome (MetS) and associated conditions. MetS, characterized by a cluster of metabolic abnormalities, significantly increases the risk of cardiovascular disease (CVD), obesity, insulin resistance, and type 2 diabetes mellitus (T2DM). The dysbiosis of gut microbiota, marked by changes in microbial composition and function, has been implicated in the pathogenesis of MetS. Main body This review synthesizes recent findings elucidating the influence of GM composition and microbiota-derived metabolites on MetS pathogenesis and progression. Notably, alterations in GM composition and dysregulation of metabolites such as short-chain fatty acids (SCFAs), trimethylamine N-oxide (TMAO), polyamines, amino acids, and indole derivatives have been implicated in MetS development. These metabolites play crucial roles in metabolic processes, and their imbalance can trigger or exacerbate metabolic disturbances associated with MetS. Various therapeutic approaches, including dietary interventions, probiotics, prebiotics, and precision medicine targeting specific metabolites, offer promising strategies for managing MetS. These interventions aim to restore a healthy GM balance and regulate the production of beneficial metabolites. Conclusion The complexity of GM interactions and their systemic effects necessitate more standardized research methodologies. Future investigations focusing on personalized therapeutic interventions and non-invasive diagnostic tools are warranted to address the complexities of MetS management. Advancing our understanding of the GM-metabolite-MetS axis will be crucial for developing effective, targeted treatments and improving patient outcomes in MetS.

Crosstalk between intestinal flora and human iron metabolism: the role in metabolic syndrome-related comorbidities and its potential clinical application

Intestinal Crosstalk Between Microbiota and Serotonin and Its Impact on Gut Motility

Gut Microbiota Disorders and Metabolic Syndrome: Tales of a Crosstalk Process

Gut microbiota bridges the iron homeostasis and host health

Gut Microbiota, Immunity, and Bile Acid Metabolism: Decoding Metabolic Disease Interactions

Dietary Strategies for Management of Metabolic Syndrome: Role of Gut Microbiota Metabolites

Interaction Between Microbes and Host Intestinal Health: Modulation by Dietary Nutrients and Gut-Brain-Endocrine-Immune Axis

The Intervention Effect of Traditional Chinese Medicine on the Intestinal Flora and Its Metabolites in Glycolipid Metabolic Disorders

Role of the intestine and its gut microbiota in metabolic syndrome and obesity

Intestinal Microbiota-Associated Metabolites: Crucial Factors in the Effectiveness of Herbal Medicines and Diet Therapies

Intestinal Flora Derived Metabolites Affect the Occurrence and Development of Cardiovascular Disease

Intestinal Microbiota-Derived Short Chain Fatty Acids in Host Health and Disease

Modulation of Intestinal Flora by Dietary Polysaccharides: A Novel Approach for the Treatment and Prevention of Metabolic Disorders

Gut microbiota-derived metabolites: implications for metabolic syndrome and therapeutic interventions

Metabolite interactions between host and microbiota during health and disease: Which feeds the other?

The role of iron in host–microbiota crosstalk and its effects on systemic glucose metabolism

Advances in Gut Microbiota-Targeted Therapeutics for Metabolic Syndrome

Gut Microbiota and Metabolic Syndrome: Relationships and Opportunities for New Therapeutic Strategies

The role of microbiota-mitochondria crosstalk in pathogenesis and therapy of intestinal diseases

Iron Reshapes the Gut Microbiome and Host Metabolism

Biomolecular Actions by Intestinal Endotoxemia in Metabolic Syndrome